Testing Radical Prostatectomy in Chinese Men With Prostate Cancer and oligoMetastases to the Bone

• Status: Recruiting
• Trial end date: 2022-03-31
• Target enrollment: 0
• Participant gender: Male

Summary

This study is to examine whether radical prostatectomy can impact survival and quality-of-life in men with oligo-metastatic prostate cancer.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fudan University
• Collaborator: University College, London

Criteria

Inclusion Criteria:

• Participants is willing and able to give informed consent for participation in the study

• Male aged 19-75 years.

• Diagnosed with oligo-metastatic prostate cancer (1-3 skeletal lesions on bone specific imaging, no visceral metastases).

• Locally resectable tumor (clinical/radiological stage T1-T3).

• Eastern Cooperative Oncology Group (ECOG) performance status 0-1.

• Suitable for radical prostatectomy within 12 months of starting standard care.

Exclusion Criteria:

• Contraindications to radical prostatectomy.

• Visceral metastases.

• Prior radiotherapy to the abdomen/pelvis or to skeletal metastases.

• Any systemic therapy of prostate cancer (including standard care) for 12 or more months prior to enrollment.

• Current involvement in other interventional research.